X2M Connect Ltd (ASX: X2M) has signed an agreement with Riverstown to offer its Smart Energy solution across the 800-lot Glanmire Park estate in Yarrawonga, Victoria, representing an estimated ~$1.6 million revenue opportunity assuming full adoption.
The deal builds on recent momentum, following a Smart Community Agreement with Resi Ventures covering 1,000 lots at McMahon’s Place, alongside a non-binding MOU targeting expansion across a further ~4,000 lots in Victoria and Queensland (announced 2 April 2026).
Refer to ASX: X2M announcements for full details!
Across Markets…
Australian shares advanced on Tuesday while oil retreated as investors banked on a potential resolution to the Middle East war, even as the US blockade of the Strait of Hormuz began.
The S&P/ASX 200 Index rose 44.8 points, or 0.5 per cent, to 8970.8, with six of the 11 sectors stronger. Sentiment was positive across Asian equities as markets weighed comments from US President Donald Trump that left open the door to further talks between Washington and Iran ahead of a ceasefire deadline next week.
It came as the US began its blockade, restricting vessels entering and leaving Iranian ports. Brent crude fell 0.8 per cent to $US98.55 a barrel on expectations the move could still form part of a negotiated outcome.
“Equities do what they always do. They look through the noise and start trading the horizon beyond it. It is beginning to price the world that comes after it,” SPI Asset Management managing partner Stephen Innes said.
“When traders sense that Washington is looking for a way out rather than a way in, crude stops behaving like a scarcity signal and starts behaving like a negotiating chip,” he said.
On the ASX, technology was the strongest sector after Monday’s heavy losses. WiseTech Global jumped 3.8 per cent to $38.56, Xero 3.9 per cent to $73.18 and Life360 3.7 per cent to $18.58.
Materials rose as BHP added 3.2 per cent to $56.10 after China’s state-backed iron ore buyer told several steel mills in the country they were allowed to purchase some of the Australian miner’s cargoes following a months-long commercial dispute. Fortescue added 1.6 per cent to $20.60 and Rio Tinto 1.3 per cent to $174.29.
Source: AFR
Critica’s Jupiter Pilot Plant Achieves 81% MagREO Recovery, Boosting Scoping Study Confidence
-
Pilot recovery rates jump to ~81% MagREO and ~71% TREO.
-
Expanded downstream testwork and ongoing Scoping Study progress.
-
Improved pilot results de-risk project development and support offtake discussions.
Critica (ASX: CRI) has significantly boosted its Jupiter pilot plant’s rare earth recovery rates, de-risking its Scoping Study progress and supporting expanded metallurgical testing.
The company achieved approximately 81% magnet rare earth oxide (MagREO) recovery and approximately 71% total rare earth oxide (TREO) recovery from representative feed material.
This marks a significant step forward, representing an approximate 45% improvement in TREO recovery from previously reported levels.
The pilot plant also delivered an intermediate concentrate with an impressive 7.5x upgrade from feed, alongside approximately 90% mass rejection.
Pilot beneficiation operations have resumed following the Lunar New Year.
Feedstock Secured for Further Testing
To facilitate ongoing work, approximately 8.5 tonnes of additional feed material has been dispatched and is en route to the Hai Phong pilot facility.
Critica anticipates a further 10-20 tonnes will be sent in the coming weeks.
This additional material is crucial for the continued production of intermediate concentrate and for advancing material qualification and offtake discussions.
Critica is currently relocating the pilot facility to a larger site, which will support increased throughput and further optimisation efforts.
Expanded Downstream Metallurgical Programs
Critica is broadening its downstream metallurgical workstreams to further refine its processing pathway.
Programs are expanding to include acid bake optimisation at ANSTO and AMML, and alternative leaching approaches at Phenikaa University.
An ongoing evaluation of heap leaching for the intermediate concentrate is also underway.
These comprehensive programs aim to further de-risk the processing pathway for Jupiter’s rare earths.
Scoping Study Remains on Track
The company has reaffirmed that the Jupiter Scoping Study remains firmly on track for completion.
These improved pilot results provide critical validation for the study’s metallurgical assumptions.
Critica commenced the Scoping Study earlier this year, with Sedgman appointed to lead the work, and is targeting delivery by the end of H1 CY2026.
The latest pilot plant results show a substantial improvement in rare earth recovery rates, validating the processing pathway and providing crucial data for the ongoing Scoping Study.
The company is well-positioned with feedstock secured and expanded metallurgical testing to further de-risk the Jupiter project.
Source: SmallCaps
Company: Fin Resources Ltd (ASX:FIN)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.0065
Performance Since Entry: +54%
Company: Eden Innovations Ltd (ASX:EDE)
Sector: Construction/Clean Energy
Deal Type: Shortfall
Latest Entry Price: $0.035 with 1:2 option, strike $0.07
Price Performance Since Entry: +414%
Company: Tasman Resources Ltd (ASX:TAS)
Sector: Gold/Silver/Mining
Deal Type: Placement
Latest Entry Price: $0.0125 with 1:2 option, strike $0.02
Price Performance Since Entry: +276%
Company: Locksley Resources Ltd (ASX:LKY)
Sector: REE & Antimony/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +338%
Company: CuFe Ltd (ASX:CUF)
Sector: Copper/Mining
Deal Type: Placement
Latest Entry Price: $0.016 with 1:2 option, strike $0.025
Price Performance Since Entry: +138%
Company: Tambourah Metals Ltd (ASX:TMB)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +23%
Company: Biotron Ltd (ASX:BIT)
Sector: Biotech
Deal Type: Placement
Latest Entry Price: $0.003 with 1:2 option, strike $0.02
Price Performance Since Entry: 0%
Company: Eclipse Metals Ltd (ASX:EPM)
Sector: REE
Deal Type: Placement
Latest Entry Price: $0.015
Price Performance Since Entry: +20%
Company: Neuren Pharmaceuticals Ltd (ASX:NEU)
Sector: Biotech
Deal Type: On-market purchase
Latest Entry Price: $1.20 – $1.50
Price Performance Since Entry: +1,116%
Company: Dimerix Ltd (ASX:DXB)
Sector: Biotech
Deal Type: Rights Issue
Raise Amount: $800,000
Latest Entry Price: $0.08 with 1:1 option, strike $0.126
Price Performance Since Entry: +375%
Sector: Blockchain
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.02 with 1:1 option $0.08 strike
Price Performance Since Entry: -5%
Company: Critica Limited (ASX:CRI)
Sector: REE
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.0075 with a 1:1 CRIO
Price Performance Since Entry: +233%
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.09 with 1:2 PL3O
Price Performance Since Entry: +100%
Sector: Gold/Mining
Deal Type: Placement
Raise Amount: $2.3M
Latest Entry Price: $0.026 with 1:2 option $0.032 strike
Price Performance Since Entry: +50%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
Comments are closed